Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
AstraZeneca
AZN
|
+$810M |
| 2 |
Intuitive Surgical
ISRG
|
+$705M |
| 3 |
S&P Global
SPGI
|
+$439M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$361M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$253M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$605M |
| 2 |
FedEx
FDX
|
+$587M |
| 3 |
Monster Beverage
MNST
|
+$395M |
| 4 |
McDonald's
MCD
|
+$387M |
| 5 |
Booking.com
BKNG
|
+$380M |
Sector Composition
| 1 | Technology | 22.3% |
| 2 | Consumer Discretionary | 16.25% |
| 3 | Healthcare | 15.51% |
| 4 | Financials | 12.99% |
| 5 | Communication Services | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SIVB
351
DELISTED
SVB Financial Group
SIVB
| $27.6M | 0.03% |
+88,753
| New | +$27.6M |
|
352
CME Group
CME
$93.7B
| $27.5M | 0.03% |
161,782
+155,328
| +2,407% | +$26.4M |
|
353
Valero Energy
VLO
$49.2B
| $27.4M | 0.03% |
240,533
+39,203
| +19% | +$4.46M |
|
354
Wendy's
WEN
$1.87B
| $27.1M | 0.02% |
1,579,385
-149,413
| -9% | -$2.56M |
|
|
DNKN
355
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $26.9M | 0.02% |
+365,184
| New | +$26.9M |
|
356
Lamb Weston
LW
$7.79B
| $26.3M | 0.02% |
+394,984
| New | +$26.3M |
|
357
Laureate Education
LAUR
$4.09B
| $26.2M | 0.02% |
1,697,214
-149,595
| -8% | -$2.31M |
|
358
Allison Transmission
ALSN
$7.41B
| $25M | 0.02% |
481,625
-606,481
| -56% | -$31.5M |
|
359
Olin
OLN
$2.92B
| $24.7M | 0.02% |
962,982
-15,983
| -2% | -$410K |
|
360
Ameris Bancorp
ABCB
$5.07B
| $24.7M | 0.02% |
540,229
-20,571
| -4% | -$940K |
|
361
DigitalBridge
DBRG
$2.03B
| $24.5M | 0.02% |
1,007,695
-8,615
| -0.8% | -$210K |
|
|
AQUA
362
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $24.5M | 0.02% |
1,379,133
-780,477
| -36% | -$13.9M |
|
363
Coca-Cola
KO
$292B
| $24.3M | 0.02% |
525,829
+170,203
| +48% | +$7.86M |
|
364
Verizon
VZ
$183B
| $24.3M | 0.02% |
+454,815
| New | +$24.3M |
|
365
Target
TGT
$41.3B
| $24.3M | 0.02% |
+275,249
| New | +$24.3M |
|
366
Q2 Holdings
QTWO
$5.13B
| $24.1M | 0.02% |
397,945
-356
| -0.1% | -$21.6K |
|
367
CRISPR Therapeutics
CRSP
$4.71B
| $24M | 0.02% |
+540,887
| New | +$24M |
|
368
MGP Ingredients
MGPI
$588M
| $24M | 0.02% |
303,406
+60,650
| +25% | +$4.79M |
|
369
Pure Storage
PSTG
$26.5B
| $23.9M | 0.02% |
920,251
-80,743
| -8% | -$2.1M |
|
370
ManpowerGroup
MAN
$1.75B
| $23.7M | 0.02% |
+275,311
| New | +$23.7M |
|
|
QVCGA
371
QVC Group, Inc. Series A Common Stock
QVCGA
$83.7M
| $23.6M | 0.02% |
21,879
-1,894
| -8% | -$2.04M |
|
|
EPZM
372
DELISTED
Epizyme, Inc
EPZM
| $23.3M | 0.02% |
2,201,037
+16,249
| +0.7% | +$172K |
|
|
TVTY
373
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $23.1M | 0.02% |
718,371
-1,412
| -0.2% | -$45.4K |
|
374
Southern Copper
SCCO
$82.9B
| $22.9M | 0.02% |
557,624
-42,472
| -7% | -$1.74M |
|
375
Travere Therapeutics
TVTX
$2.43B
| $22.8M | 0.02% |
794,319
-276,008
| -26% | -$7.93M |
|